Johnson & Johnson (JNJ) Accumulated Expenses (2009 - 2026)

Johnson & Johnson's Accumulated Expenses history runs 18 years deep, the most recent figure standing at $7.4 billion for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 190.04% year-over-year to $7.4 billion; the TTM figure through Mar 2026 stood at $7.4 billion (up 190.04% YoY), while the FY2025 annual figure was $8.6 billion, up 108.29% from the prior year.
• Accumulated Expenses came in at $7.4 billion for Q1 2026 at Johnson & Johnson, down from $8.6 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $13.0 billion in Q2 2022 to a low of $2.6 billion in Q1 2025.
• A 5-year average of $7.4 billion and a median of $7.0 billion in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 531.36% in 2022 and slumped 63.66% in 2025, its largest moves.
• Johnson & Johnson's Accumulated Expenses stood at $12.0 billion in 2022, then tumbled by 66.59% to $4.0 billion in 2023, then grew by 3.33% to $4.1 billion in 2024, then soared by 108.29% to $8.6 billion in 2025, then retreated by 13.91% to $7.4 billion in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $7.4 billion, $8.6 billion, and $6.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison